Who
Marion McCourt
EVP Commercial
Company insider
Files Form 4 as: EVP Commercial, Regeneron Pharmaceuticals; Director, Scynexis; Director, CytomX Therapeutics; Principal Operating Officer, Axovant Sciences; Chief Operating Officer, Medivation.
In numbers
- Trades disclosed
- 174
- Buys
- 0
- Sells
- 51
- Bought
- $0
- Sold
- $35.0M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 3 Feb 2016
- Last trade
- 3 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 3 Sep 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $970K1,131 at $857.39 | filing |
| 3 Sep 2026filed 3 Sep 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $970K1,131 at $857.39 | filing |
| 2 Sep 2026filed 3 Sep 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.0M1,215 at $850.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.0M1,215 at $850.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $716K1,021 at $701.51 | filing |
| 8 Dec 2025filed 9 Dec 2025 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $952K1,336 at $712.94 | filing |
| 5 Dec 2025filed 9 Dec 2025 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,210 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,476 at $0.00 | filing |
| 16 Dec 2024filed 18 Dec 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $555K759 at $730.81 | filing |
| 9 Dec 2024filed 10 Dec 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $216K274 at $787.00 | filing |
| 6 Dec 2024filed 10 Dec 2024 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,981 at $0.00 | filing |
| 6 Dec 2024filed 10 Dec 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,332 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $381K1,000 at $381.40 | filing |
| 1 Nov 2024filed 5 Nov 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $845K1,000 at $844.61 | filing |
| 1 Oct 2024filed 3 Oct 2024 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 1 Oct 2024filed 3 Oct 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $381K1,000 at $381.40 | filing |
| 1 Oct 2024filed 3 Oct 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1.1M1,000 at $1,054.06 | filing |
| 3 Sep 2024filed 5 Sep 2024 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 3 Sep 2024filed 5 Sep 2024 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $381K1,000 at $381.40 | filing |
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Marion McCourt; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.